Search clinical trials for: BI 691751 low dose 2
Total 0 results
Nothing found
Sponsors and Collaborators
- Maria de las Mercedes Perez Rodriguez
- Worabe Comprehensive Specialiazed Hospital
- Shenzhen Core Medical Technology CO.,LTD.
- Hospital Governador Celso Ramos
- Sociedad Panameña de Hematología
- Pompeyo Stalin Alarcón Vigil
- Nelson Mandela Academic Hospital
- Saw Swee Hock School of Public Health
- Didem OZKAL EMINOGLU
- Universidad Mayor de San Simón (UMSS, Bolivia)
- The Institute of Neuropsychiatry and Addictions (INAD), Parc de Salut Mar, Barcelona
- Sub-Investigator: Łucja Bieleninik, PhD
- Shaoxing Mashan Street Community Health Service Center
- Donald B. Kohn, M.D.
- Steven B. Kleiboeker
- Dr. Jochen Brack
- Roongroj Bhidayasiri
- MYOR Ltd.
- Pharmacy Board of Sierra Leone, Ministry of Health and Sanitation
- Centre Hospitalier du Quebec
- View Full List
Medical Conditions
- Endoscopic Surveillance
- Urinary Bladder Neurogenic Dysfunction
- Neuroectodermal Tumor
- Pharmacokinetics of Ipragliflozin
- 0.5-14 Year Old Children With Nephroblastoma
- Root Abscess
- Inoperable Stage III Non-small Cell Lung Cancer
- Parental
- Granulomatous Disease, Chronic
- Bladder Cancer Recurrent
- Malignant Tumor of Urinary System (Disorder)
- Poor Medication Adherence
- Anticoagulant Prophylaxis/Therapy
- Small Intestine Cancer
- Control Nausea and Vomiting
- Memory Disorders
- Humerus Fracture Displaced Proximal
- Bladder Recurrence
- Macrocephaly Autism Syndrome
- Atherosclerosis Coronary Artery With Angina Pectoris
- View Full List
Drug Interventions
- Varenicline Controlled Release 1.2 mg
- FTD regimen
- Fibrin Sealant
- Bupropion Extended Release Oral Tablet
- Campath 1H
- Everolimus
- Ceralasertib
- APG2575 800 mg
- Rabeprazole, amoxicillin, tetracycline, furazolidone (only for the first 7 days), colloidal bismuth pectin (for the second 7 days)
- Vehicle
- Salvinorin A
- Elafibranor 80mg
- Idelalisib
- Letrozole
- SAR408701 (Tusamitamab ravtansine)
- Cyclosporine A
- Biphasic insulin aspart 30
- Clozapine 100 mg
- The drug "Rutan 0.1".
- Sparsentan
- View Full List
CROs by country
- Contract Research Organizations in Czech Republic
- Contract Research Organizations in France
- Contract Research Organizations in Italy
- Contract Research Organizations in Kuwait
- Contract Research Organizations in Malaysia
- Contract Research Organizations in Mali
- Contract Research Organizations in Mauritius
- Contract Research Organizations in Montenegro
- Contract Research Organizations in Peru
- Contract Research Organizations in Qatar
- Contract Research Organizations in Sri Lanka
- Contract Research Organizations in Thailand
- Contract Research Organizations in Venezuela
- CRO list by country